Spain Pharmaceutical Logistics Market Size (2024 - 2029)

Spain Pharmaceutical Logistics Market Analysis

The Spain Pharmaceutical Logistics Market size is estimated at USD 5.63 billion in 2024, and is expected to reach USD 7.31 billion by 2029, at a CAGR of greater than 4.40% during the forecast period (2024-2029).

Spain is set to lead the world in 'pharma growth potential' in 2024, with Barcelona emerging as Europe's second-best hub for biotech investment.

With a growing number of international biotech startups and companies eyeing Barcelona and its metropolitan area, the Catalan capital is solidifying its position as a biotech stronghold. Reports indicate that by 2024, Spain will rank sixth globally and third in Europe for 'pharma growth potential.'

The booming pharmaceutical industry in Spain is poised to bolster the country's pharmaceutical logistics market, paving the way for lucrative opportunities in transporting and storing both temperature-sensitive and general pharmaceutical products.

Spain boasts 103 factories dedicated to producing medicines for human use, with 11 specializing in biologics. When factoring in 46 facilities for active ingredients and 24 for veterinary use, the total rises to 173 factories, spread across 122 distinct business groups. Collectively, they generate 183,000 jobs (encompassing direct, indirect, and induced employment), produce goods worth EUR 16 billion (USD 16.79 billion) (with 75% earmarked for export), and lead in both competitiveness and environmental sustainability.

In 2023, prescription medications dominated Spain's pharmaceutical market, accounting for nearly 70% of the revenue. Over-the-counter medications followed at 12.4%, while nutritional products made up about 3%. That year, Spain boasted approximately 22,261 pharmacies, translating to one pharmacy for every 2,130 residents.

In 2023, Spain's pharmaceutical imports were valued at around USD 22 billion, a slight dip from the USD 24 billion in 2022. Notably, over the analyzed period, imports surged by more than 4.2 times.

This robust growth of the pharmaceutical industry in Spain will support the advancement of the Spanish pharmaceutical logistics market by creating tremendous opportunities for the transport and storage of temperature-sensitive and general pharmaceutical products in the country.

The increasing demand for efficient logistics solutions will drive investments in infrastructure, technology, and services, ensuring the safe and timely delivery of pharmaceutical products. Consequently, the Spanish pharmaceutical logistics market is expected to experience significant growth, solidifying its position as a critical component of the global pharmaceutical supply chain.

Spain Pharmaceutical Logistics Industry Segmentation

Pharmaceutical logistics is concerned with the production, processing, and transportation of materials, as well as the resources and activities associated with the handling of manufactured items by their consumers. Logistics businesses are critical to the operation of any pharmaceutical company.

A comprehensive background analysis of the Spain Pharmaceutical Logistics Market, covering the current market trends, restraints, technological updates, and detailed information on various segments and the competitive landscape of the industry. The impact of COVID-19 has also been incorporated and considered during the study.

Spain's pharmaceutical logistics market is segmented by product (generic drugs, branded drugs), by mode of operation (cold chain logistics, non-cold chain logistics), by application (bio-pharma, chemical pharma), and by mode of transport (air shipping, rail shipping, road shipping, sea shipping). The report offers market size and forecasts for the Spain Pharmaceutical Logistics market in value (usd billion) for all the above segments.